COMMUNIQUÉS West-GlobeNewswire

Context Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress
05/08/2026
Prioritization of CTIM-76 and CT-202 clinical programs, with initial clinical readouts expected beginning in Q2 2027 Cash and cash equivalents of $43.0 million as of June 30, 2026 expected to fund operations into Q4 [...]
Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026
05/08/2026
WOBURN, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company"), a U.S. specialty dermatology company commercializing Ameluz ® (aminolevulinic acid hydrochloride) Gel, [...]
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
05/08/2026
– LOQTORZI ® net revenue of $13.6 million in Q2 2026, up 15% over Q1 – – Clinical data continue to mature across programs with emerging evidence of activity with tagmokitug in head and neck cancer – – Projected October [...]
STERIS Announces Financial Results for Fiscal 2027 First Quarter
05/08/2026
Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6% Fiscal 2027 first quarter as reported diluted EPS increased to $2.04; adjusted EPS per diluted share increased to $2.59 [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
05/08/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 05 août 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Monthly information on share capital and company voting rights
05/08/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]
BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates
05/08/2026
First participant dosed in QUELL-CV, a Phase 2 dose-ranging proof-of-concept trial of BGE-102 measuring inflammatory and cardiometabolic biomarkers; topline data anticipated in the second half of 2026 QUELL-DME, Phase [...]
Pacific Health Care Organization, Inc. Reports its Second Quarter 2026 Financial Results
05/08/2026
Irvine, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) filed yesterday with the Securities and Exchange Commission (the “SEC”) its quarterly report on [...]
New 23andMe Research Institute Study First to Identify Association Between Specific Side Effects from Common Antidepressants and Genetics
05/08/2026
Study with more than 100,000 consented participants shows CYP2C19 genetic variation is associated with an individual’s risk of side effects and their continued use of serotonin reuptake inhibitors (SSRIs) PALO ALTO, [...]
RXR Nuclear Receptor Agonists Promote Clearance of Alpha-Synuclein in Cellular Models
05/08/2026
Investigators Present Data Supporting Disease-Modifying Potential of the Io Therapeutics RXR Agonist Compound IRX4204 in Parkinson’s Disease SPRING, Texas, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a [...]
Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week
05/08/2026
Canton, Ohio—As thousands of football fans descend on Canton for the 2026 Pro Football Hall of Fame Enshrinement Week, Smith+Nephew, the Global medical technology company, will join the celebration with a series of [...]
JellyBlue Launch 2026 New Advanced Gummies For Men's Performance And Vitality Support in the USA. JellyBlue Supplement Facts And ingredients Highlights,
05/08/2026
JellyBlue announces the launch of JellyBlue Gummies, a natural Supplement developed for adult men's health to support Performance, energy and Vitality. The new daily formula combines carefully selected ingredients with [...]
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
05/08/2026
Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three [...]
Athelas Launches Practice Manager, the World's First Agentic Practice Management Suite
05/08/2026
One platform. 7% of US healthcare appointments. Billions in claims. Practice Manager debuts alongside the new athelas.com website. SAN FRANCISCO, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Athelas , powered by Commure, today [...]
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
05/08/2026
TAIZHOU, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company”), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value [...]
PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
05/08/2026
Vega SPRQ-Nx chemistry to deliver up to 90 Gb per run at 40% lower cost per gigabase, with single-shift runs and new workflow controls for regulated labs MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio ( [...]
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05/08/2026
In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), please note that in the first paragraph of the release, the time should be 7:00 am Eastern [...]
Acentra Health Acquires FEI Systems to Expand Technology and Clinical Solutions for Medicaid, Long-Term Services and Supports, Home- and Community-Based Services, and Behavioral Health
05/08/2026
Combined company creates a premier partner for government healthcare programs with end-to-end clinical services and modern health technology solutions MCLEAN, Va., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a [...]
Stryker declares an $0.88 per share quarterly dividend
05/08/2026
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable October 30, 2026, to shareholders of record at [...]

Pages